Home News & Events Events Events Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any - Industry Webinars Workshop Industry Obesity Week 2026 Date 14 November 2026 - 17 November 2026 Time 08:00 - 18:00 Location Washington DC, USA Timezone EDT - America/New York ICON will exhibit Industry EBF Date 17 November 2026 - 19 November 2026 Time 08:00 - 18:00 Location Barcelona, Spain Timezone Europe/Madrid ICON will exhibit and speak Industry SCDM India Date 3 December 2026 - 5 December 2026 Time 08:00 - 18:00 Location Bengaluru, India Timezone IST - Asia/Kolkata ICON will exhibit and speak Previous 1 … 3 4 5 In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What's happening in ICON ICON Plc Heading to Philadelphia for #ISPORAnnual? Our ICON HEOR and RWE teams will be on-site sharing the latest thinking on patient-centred outcomes, comparative effectiveness research, and innovative evidence synthesis. Let’... 23h View post View webpage ICON Plc Ankita Minhas will speak on 6 May at OCT Europe in Barcelona at 12:00pm in Stream C. Her session will explore how leading biotechs manage rising complexity through AI-driven innovation, smarter trial designs, and stronge... 4 May View post View webpage ICON Plc Meet the ICON team at SCDM #EMEA26, to discover how we are driving innovation in clinical data science and helping organisations build smarter, more resilient clinical programmes. Visit us at booth 11 to explore how IC... 1 May View post View webpage ICON Plc What is it really like to build a career as a Senior Clinical Research Associate at ICON? In our latest careers blog, Rafi Cabral, MD ,CCRP shares his experience of life as a CRA, from partnering with study sites and su... 30 Apr View post View webpage ICON Plc Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our free monthly publication b... 30 Apr View post View webpage ICON Plc Participant-centric study design has advanced, but site-centric execution has not kept pace. In the Journal for Clinical Studies, Brian Mallon examines how unclear expectations, administrative burden and contract delays ... 30 Apr View post View webpage ICON Plc Oligonucleotide (ON) drug development is accelerating rapidly—but first in human (FIH) studies remain complex. Join our upcoming webinar to explore key translational and clinical considerations for initiating FIH antis... 30 Apr View post View webpage ICON Plc Faster study start up starts with the right sites, and the right tools. Speak with us at ASCO, booth \#35093 to learn about ICON’s purpose built technology suite that helps sponsors identify, activate and collaborate wi... 30 Apr View post View webpage ICON Plc Great discussion recently at European Pharmaceutical Review’s webinar, “Harnessing AI for more efficient clinical trials.” ICON’s SVP of Enterprise AI, Tony Clarke, joined a panel of industry leaders to share perspectiv... 30 Apr View post View webpage ICON Plc ICON proudly supports World Immunisation Week. In our new vaccine whitepaper, ICON experts discuss how planning for long-term follow-up early in the vaccine development process is critical to effectively collecting and u... 29 Apr View post View webpage ICON Plc Selecting the right evidence generation method NMA, MAIC, STC and ML NMR each have distinct advantages and limitations. Our whitepaper provides a comparative overview to help researchers and sponsors choose the most a... 29 Apr View post View webpage ICON Plc Patient safety and data integrity are the primary concerns in early phase clinical trials. In the US sponsors generally follow one of two standards sets when conducting early phase trials: Good Manufacturing Practice (GM... 29 Apr View post View webpage
